Takeda Pharmaceutical (TAK) Exchange Rate Effect (2018 - 2026)

Takeda Pharmaceutical has reported Exchange Rate Effect for 9 years, with the latest figure at $39.9 million in Q2 2026.

• On a quarterly basis, Exchange Rate Effect rose 336.92% year-over-year to $39.9 million in Q2 2026; TTM through Jun 2026 was $50.2 million, a 123.88% increase from a year earlier, with the FY2026 full-year figure at $219.8 million, up 394.1% from the prior year.
• Exchange Rate Effect was $39.9 million for Q2 2026 at Takeda Pharmaceutical, down from $90.7 million in the prior quarter.
• The five-year high for Exchange Rate Effect was $193.6 million in Q1 2022, with the low at -$280.1 million in Q3 2024.
• Average Exchange Rate Effect over 5 years is $36.8 million, with a median of $55.6 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Exchange Rate Effect jumped 10358.94% in 2022, then slumped 1111.37% in 2024.
• Over 5 years, Exchange Rate Effect stood at -$67.8 million in 2022, then surged by 68.92% to -$21.1 million in 2023, then jumped by 814.13% to $150.5 million in 2024, then plunged by 39.73% to $90.7 million in 2025, then slumped by 56.04% to $39.9 million in 2026.
• The last three Exchange Rate Effect figures came in at $39.9 million (Q2 2026), $90.7 million (Q3 2025), and -$16.8 million (Q2 2025), per Business Quant data.